GlassScriptPhysician profile
Wayne A Hudec
NPI 1386658540
$1,417.98
in general payments reported to CMS, 2019-2025
25 companies · $165 in 2025
The $165 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $271 · 2020: $110 · 2021: $334 · 2022: $241 · 2023: $148 · 2024: $149 · 2025: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $442 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $441.83 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $278.12 | 2021-2024 | Kcentra |
| Ethicon US, LLC | $128.85 | 2019-2021 | |
| Angiodynamics, INC. | $96.37 | 2019-2021 | |
| Organogenesis INC. | $85.82 | 2022-2024 | Puraply |
| Davol INC. | $85.26 | 2020-2022 | |
| Pacira Pharmaceuticals Incorporated | $82.81 | 2019-2025 | Exparel, Iovera, Zilretta |
| Medtronic, INC. | $65.60 | 2021-2024 | Ligasure |
| Midsouth Orthopedics INC. | $62.75 | 2019-2022 | |
| Tela Bio, INC. | $55.55 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Kls-Martin L.P. | $52.60 | 2025 | |
| Integra Lifesciences Corporation | $51.10 | 2019 | |
| Kci USA, INC. | $48.17 | 2021-2023 | Activ.A.C. Ion Progress, V.A.C. Dermatac |
| Solventum Corporation | $38.46 | 2024-2025 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Avanos Medical | $37.27 | 2024 | Entral |
| Innocoll Pharmaceuticals Limited | $35.32 | 2021-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu INC. | $30.98 | 2022 | |
| Getinge USA Sales, LLC | $30.84 | 2021 | |
| Intuitive Surgical, INC. | $27.79 | 2020 | |
| Polynovo North America LLC | $26.36 | 2023 | |
| Teleflex LLC | $22.67 | 2023 | Quikclot |
| Boston Scientific Corporation | $16.69 | 2019 | |
| Covidien LP | $15.96 | 2019 | |
| Phathom Pharmaceuticals, INC. | $15.29 | 2025 | Voquezna |
| Takeda Pharmaceuticals U.S.A., INC. | $13.72 | 2023 | Gattex |
| Merck Sharp & Dohme LLC | $13.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Hudec listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.